Biblio Discovery — Demo Discovery Service

9 results for "Samit Ganguly"

Showing 1–9 · 0.75 seconds · RSS

  1. Journal Article

    External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data

    Eleni Karatza; Samit Ganguly; Chi D. Hornik et al.

    Frontiers in Pharmacology, Vol. 13 · 2022 · English · DOAJ Scopus

    Risperidone is approved to treat schizophrenia in adolescents and autistic disorder and bipolar mania in children and adolescents. It is also used off-label in younger children for various psychiatric disorders. Several population pharmacokinetic models of risperidone and 9-OH-risperidone have been…

  2. Journal Article

    Non-affine extensions of the Raychaudhuri equation in the K-essence framework

    Samit Ganguly; Goutam Manna; Debashis Gangopadhyay et al.

    Physics Letters B, Vol. 868 · 2025 · English · DOAJ Scopus

    We present a new avenue of the Raychaudhuri Equation (RE) by introducing a non-affine parametrization within the k-essence framework. This modification accounts for non-geodesic flow curves, leading to emergent repulsive effects in cosmic evolution. Using a DBI-type k-essence Lagrangian, we derive…

  3. Journal Article

    CD20×CD3 Bispecific Antibodies in B‐NHL: A Review of Translational Science, Pharmacokinetics, Pharmacodynamics, and Dose Strategy in Clinical Research

    Min Zhu; Xiaowen Guan; Samit Ganguly et al.

    Clinical and Translational Science, Vol. 18 No. 6 · 2025 · English · DOAJ Scopus

    ABSTRACT Despite advancements in treatment for B‐cell non‐Hodgkin lymphoma (B‐NHL) in recent decades, many patients still relapse or are refractory to treatment, which represents a high unmet medical need. Novel CD20 × CD3 T‐cell–engaging bispecific antibodies (bsAbs) have created a new paradigm…

  4. Journal Article Full text

    Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters

    Samit Ganguly; David Finkelstein; Timothy I. Shaw et al.

    PLOS ONE, Vol. 16 No. 7 · 2021 · English · PLOS Scopus

    Abcg2/Bcrp and Abcb1a/Pgp are xenobiotic efflux transporters limiting substrate permeability in the gastrointestinal system and brain, and increasing renal and hepatic drug clearance. The systemic impact of Bcrp and Pgp ablation on metabolic homeostasis of endogenous substrates is incompletely…

    Also available at: DOAJ

  5. Journal Article

    The role of large immune complexes in anti-drug antibody development: a case study of anti-SARS-CoV-2 antibody therapeutics and co-administered mRNA vaccine

    Susan C. Irvin; Zhiqiang Wang; Samit Ganguly et al.

    Frontiers in Immunology, Vol. 17 · 2026 · English · DOAJ Scopus

    The administration of therapeutic proteins may induce an anti-drug antibody (ADA) response which may impact pharmacokinetics, safety or efficacy. Numerous factors contribute to ADA development, such as patient population, drug sequence, formulation impurities, as well as drug dose and frequency…

  6. Journal Article

    Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study

    Jing Xiao; Paula Dakin; Gregory P Geba et al.

    BMJ Open, Vol. 14 No. 10 · 2024 · English · DOAJ Scopus

    Objective Pregnant women with COVID-19 are at elevated risk for severe outcomes, but clinical data on management of these patients are limited. Monoclonal antibodies, such as casirivimab plus imdevimab (CAS+IMD), have proven effective in treating non-pregnant adults with COVID-19, prompting further…

  7. Journal Article

    Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain

    Selin Somersan-Karakaya; Kenneth C. Turner; Luz Cortes-Burgos et al.

    Neurobiology of Pain, Vol. 14 · 2023 · English · DOAJ Scopus

    The artemin-GFRα3 signaling pathway has been implicated in various painful conditions including migraine, cold allodynia, hyperalgesia, inflammatory bone pain, and mouse knees contain GFRα3-immunoreactive nerve endings. We developed high affinity mouse (REGN1967) and human (REGN5069) GFRα3-blocking…

  8. Journal Article

    Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19

    Flonza Isa; Eduardo Forleo-Neto; Jonathan Meyer et al.

    International Journal of Infectious Diseases, Vol. 122 · 2022 · English · DOAJ Scopus

    Objectives: A phase 1, double-blind, placebo-controlled trial was conducted to evaluate the safety, tolerability, and exploratory efficacy of repeat monthly doses of subcutaneous (SC) casirivimab and imdevimab (CAS+IMD) in uninfected adult volunteers. Methods: Participants were randomized (3:1) to…